457 related articles for article (PubMed ID: 23896458)
1. Inconvenient truth: cancer biomarker development by using proteomics.
Kondo T
Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
[TBL] [Abstract][Full Text] [Related]
2. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
Farina A
Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
[TBL] [Abstract][Full Text] [Related]
3. Towards defining biomarkers indicating resistances to targeted therapies.
Stehle F; Schulz K; Seliger B
Biochim Biophys Acta; 2014 May; 1844(5):909-16. PubMed ID: 24269379
[TBL] [Abstract][Full Text] [Related]
4. Biomarker research with prospective study designs for the early detection of cancer.
Pesch B; Brüning T; Johnen G; Casjens S; Bonberg N; Taeger D; Müller A; Weber DG; Behrens T
Biochim Biophys Acta; 2014 May; 1844(5):874-83. PubMed ID: 24361552
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
6. Innovative proteomic approaches for cancer biomarker discovery.
Faca V; Krasnoselsky A; Hanash S
Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
[TBL] [Abstract][Full Text] [Related]
7. Sieving through the cancer secretome.
Lin Q; Tan HT; Lim HS; Chung MC
Biochim Biophys Acta; 2013 Nov; 1834(11):2360-71. PubMed ID: 23376431
[TBL] [Abstract][Full Text] [Related]
8. Emerging nanoproteomics approaches for disease biomarker detection: a current perspective.
Ray S; Reddy PJ; Choudhary S; Raghu D; Srivastava S
J Proteomics; 2011 Nov; 74(12):2660-81. PubMed ID: 21596164
[TBL] [Abstract][Full Text] [Related]
9. Strategies for plasma proteomic profiling of cancers.
Omenn GS
Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
[TBL] [Abstract][Full Text] [Related]
10. [Biomarker Discovery of Colorectal Cancer Using Membrane Proteins Extracted from Cancer Tissues].
Tomonaga T; Kume H
Rinsho Byori; 2015 Mar; 63(3):322-7. PubMed ID: 26524855
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
12. [Proteomics for biomarker development toward personalized medicine].
Kondo T
Rinsho Byori; 2012 Jul; 60(7):644-9. PubMed ID: 22973724
[TBL] [Abstract][Full Text] [Related]
13. Cancer proteomics: developments in technology, clinical use and commercialization.
Yeat NC; Lin C; Sager M; Lin J
Expert Rev Proteomics; 2015 Aug; 12(4):391-405. PubMed ID: 26145529
[TBL] [Abstract][Full Text] [Related]
14. ProteinChips: the essential tools for proteomic biomarker discovery and future clinical diagnostics.
Clarke W; Chan DW
Clin Chem Lab Med; 2005; 43(12):1279-80. PubMed ID: 16309362
[No Abstract] [Full Text] [Related]
15. Tumor interstitial fluid - a treasure trove of cancer biomarkers.
Gromov P; Gromova I; Olsen CJ; Timmermans-Wielenga V; Talman ML; Serizawa RR; Moreira JM
Biochim Biophys Acta; 2013 Nov; 1834(11):2259-70. PubMed ID: 23416532
[TBL] [Abstract][Full Text] [Related]
16. Progress and prospects for the discovery of biomarkers for gastric cancer: a focus on proteomics.
Mohri Y; Toiyama Y; Kusunoki M
Expert Rev Proteomics; 2016 Dec; 13(12):1131-1139. PubMed ID: 27744719
[TBL] [Abstract][Full Text] [Related]
17. Current advances in esophageal cancer proteomics.
Uemura N; Kondo T
Biochim Biophys Acta; 2015 Jun; 1854(6):687-95. PubMed ID: 25233958
[TBL] [Abstract][Full Text] [Related]
18. Contribution of oncoproteomics to cancer biomarker discovery.
Cho WC
Mol Cancer; 2007 Apr; 6():25. PubMed ID: 17407558
[TBL] [Abstract][Full Text] [Related]
19. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
20. MALDI mass spectrometry in prostate cancer biomarker discovery.
Flatley B; Malone P; Cramer R
Biochim Biophys Acta; 2014 May; 1844(5):940-9. PubMed ID: 23831156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
